Header Logo

Connection

Douglas Corley to Early Detection of Cancer

Back to Details
This is a "connection" page, showing publications Douglas Corley has written about Early Detection of Cancer.
Douglas Corley
Connection Strength
11.691
Early Detection of Cancer
  1. Colorectal Cancer Screening After Sequential Outreach Components in a Demographically Diverse Cohort. JAMA Netw Open. 2024 Apr 01; 7(4):e245295.
    View in: PubMed
    Score: 0.654
  2. Physician Adenoma Detection Rates and Colorectal Cancer-Reply. JAMA. 2022 10 11; 328(14):1462-1463.
    View in: PubMed
    Score: 0.590
  3. Association of Physician Adenoma Detection Rates With Postcolonoscopy Colorectal Cancer. JAMA. 2022 06 07; 327(21):2114-2122.
    View in: PubMed
    Score: 0.576
  4. Rising Early-onset Colorectal Cancer Incidence Is Not an Artifact of Increased Screening Colonoscopy Use in a Large, Diverse Healthcare System. Gastroenterology. 2022 01; 162(1):325-327.e3.
    View in: PubMed
    Score: 0.549
  5. Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program. Gastroenterology. 2020 11; 159(5):1695-1704.e1.
    View in: PubMed
    Score: 0.506
  6. Promises and Potential Pitfalls of Shared Decision Making in Cancer Screening. Gastroenterology. 2020 03; 158(4):802-805.
    View in: PubMed
    Score: 0.484
  7. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2020 03; 158(4):884-894.e5.
    View in: PubMed
    Score: 0.479
  8. Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis. Gastroenterology. 2019 12; 157(6):1494-1505.
    View in: PubMed
    Score: 0.475
  9. Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death. Gastroenterology. 2019 01; 156(1):63-74.e6.
    View in: PubMed
    Score: 0.446
  10. When Should Guidelines Change? A Clarion Call for Evidence Regarding the Benefits and Risks of Screening for Colorectal Cancer at Earlier Ages. Gastroenterology. 2018 10; 155(4):947-949.
    View in: PubMed
    Score: 0.444
  11. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014 07 10; 371(2):186.
    View in: PubMed
    Score: 0.333
  12. Colorectal-cancer screening--coming of age. N Engl J Med. 2013 Sep 19; 369(12):1164-6.
    View in: PubMed
    Score: 0.315
  13. The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer? Clin Gastroenterol Hepatol. 2013 Mar; 11(3):204-7.
    View in: PubMed
    Score: 0.303
  14. The future of colon cancer screening: what do we recommend and will it be too much, too little, or just right? Gastroenterology. 2011 Dec; 141(6):1956-8.
    View in: PubMed
    Score: 0.276
  15. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. J Natl Cancer Inst. 2015 Jun; 107(6):djv120.
    View in: PubMed
    Score: 0.176
  16. Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death. JAMA Netw Open. 2024 Jul 01; 7(7):e2423671.
    View in: PubMed
    Score: 0.166
  17. Population-level impact of the BMJ Rapid Recommendation for colorectal cancer screening: a microsimulation analysis. BMJ Open Gastroenterol. 2024 May 09; 11(1).
    View in: PubMed
    Score: 0.165
  18. Evaluating Different Approaches for Calculating Adenoma Detection Rate: Is Screening Colonoscopy the Gold Standard? Gastroenterology. 2023 09; 165(3):784-787.e4.
    View in: PubMed
    Score: 0.154
  19. Developing Meaningful Health Care Quality Metrics: An Example From Colonoscopy and Adenoma Detection. Ann Intern Med. 2022 10; 175(10):1479-1480.
    View in: PubMed
    Score: 0.147
  20. Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1517-1520.
    View in: PubMed
    Score: 0.146
  21. Association between Improved Colorectal Screening and Racial Disparities. N Engl J Med. 2022 02 24; 386(8):796-798.
    View in: PubMed
    Score: 0.141
  22. Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute's PROSPR Consortium. Gastroenterology. 2021 03; 160(4):999-1002.
    View in: PubMed
    Score: 0.129
  23. Validation of an Algorithm to Identify Patients at Risk for Colorectal Cancer Based on Laboratory Test and Demographic Data in Diverse, Community-Based Population. Clin Gastroenterol Hepatol. 2020 11; 18(12):2734-2741.e6.
    View in: PubMed
    Score: 0.125
  24. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium. J Natl Cancer Inst. 2020 03 01; 112(3):238-246.
    View in: PubMed
    Score: 0.123
  25. Natural Language Processing for the Accurate Identification of Colorectal Cancer Mismatch Repair Status in Lynch Syndrome Screening. Clin Gastroenterol Hepatol. 2021 03; 19(3):610-612.e1.
    View in: PubMed
    Score: 0.123
  26. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ. 2019 Oct 02; 367:l5515.
    View in: PubMed
    Score: 0.120
  27. Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting. . 2019 07 01; 81(3):284-291.
    View in: PubMed
    Score: 0.118
  28. Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study. Ann Intern Med. 2019 07 02; 171(1):19-26.
    View in: PubMed
    Score: 0.117
  29. Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers. Gastrointest Endosc. 2019 01; 89(1):168-176.e3.
    View in: PubMed
    Score: 0.111
  30. Overdiagnosis in Colorectal Cancer Screening: Time to Acknowledge a Blind Spot. Gastroenterology. 2018 Sep; 155(3):592-595.
    View in: PubMed
    Score: 0.110
  31. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology. 2018 11; 155(5):1383-1391.e5.
    View in: PubMed
    Score: 0.110
  32. World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer. Gastroenterology. 2018 09; 155(3):909-925.e3.
    View in: PubMed
    Score: 0.110
  33. Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium. CA Cancer J Clin. 2018 05; 68(3):199-216.
    View in: PubMed
    Score: 0.108
  34. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev. 2018 02; 27(2):158-164.
    View in: PubMed
    Score: 0.105
  35. Impact of adenoma detection on the benefit of faecal testing vs. colonoscopy for colorectal cancer. Int J Cancer. 2017 12 01; 141(11):2359-2367.
    View in: PubMed
    Score: 0.104
  36. Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test. JAMA. 2017 08 01; 318(5):483.
    View in: PubMed
    Score: 0.103
  37. Primary care visit use after positive fecal immunochemical test for colorectal cancer screening. Cancer. 2017 Oct 01; 123(19):3744-3753.
    View in: PubMed
    Score: 0.102
  38. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. JAMA. 2017 Apr 25; 317(16):1631-1641.
    View in: PubMed
    Score: 0.101
  39. Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program. Am J Prev Med. 2017 Sep; 53(3):335-344.
    View in: PubMed
    Score: 0.101
  40. Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature. J Am Board Fam Med. 2016 11 12; 29(6):672-681.
    View in: PubMed
    Score: 0.098
  41. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system. Am J Obstet Gynecol. 2017 Feb; 216(2):151.e1-151.e9.
    View in: PubMed
    Score: 0.097
  42. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2018 02; 67(2):291-298.
    View in: PubMed
    Score: 0.097
  43. Endoscopist fatigue estimates and colonoscopic adenoma detection in a large community-based setting. Gastrointest Endosc. 2017 Mar; 85(3):601-610.e2.
    View in: PubMed
    Score: 0.097
  44. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System. J Gen Intern Med. 2016 11; 31(11):1323-1330.
    View in: PubMed
    Score: 0.096
  45. Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. Am J Prev Med. 2016 09; 51(3):e67-75.
    View in: PubMed
    Score: 0.095
  46. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach. J Gen Intern Med. 2016 10; 31(10):1190-7.
    View in: PubMed
    Score: 0.095
  47. Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium. JAMA. 2016 May 17; 315(19):2067-8.
    View in: PubMed
    Score: 0.095
  48. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium. J Gen Intern Med. 2016 Apr; 31(4):372-9.
    View in: PubMed
    Score: 0.094
  49. Colorectal Cancer Health Disparities and the Role of US Law and Health Policy. Gastroenterology. 2016 05; 150(5):1052-1055.
    View in: PubMed
    Score: 0.094
  50. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med. 2016 Apr 05; 164(7):456-63.
    View in: PubMed
    Score: 0.093
  51. Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR. J Comp Eff Res. 2015 Nov; 4(6):541-51.
    View in: PubMed
    Score: 0.089
  52. Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model. JAMA. 2015 Jun 16; 313(23):2349-58.
    View in: PubMed
    Score: 0.089
  53. Development and validation of an algorithm for classifying colonoscopy indication. Gastrointest Endosc. 2015 Mar; 81(3):575-582.e4.
    View in: PubMed
    Score: 0.086
  54. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015 Mar; 25(3):208-213.e1.
    View in: PubMed
    Score: 0.086
  55. Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):739-46.
    View in: PubMed
    Score: 0.085
  56. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1147-58.
    View in: PubMed
    Score: 0.083
  57. Approaches for classifying the indications for colonoscopy using detailed clinical data. BMC Cancer. 2014 Feb 15; 14:95.
    View in: PubMed
    Score: 0.081
  58. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014 Feb 04; 160(3):171.
    View in: PubMed
    Score: 0.081
  59. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology. 2013 Aug; 145(2):312-9.e1.
    View in: PubMed
    Score: 0.077
  60. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20.
    View in: PubMed
    Score: 0.076
  61. Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):37-45.
    View in: PubMed
    Score: 0.038
  62. Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines. Ann Intern Med. 2022 11; 175(11):1582-1590.
    View in: PubMed
    Score: 0.037
  63. Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings. Cancer Med. 2023 Feb; 12(3):3705-3717.
    View in: PubMed
    Score: 0.037
  64. Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1521-1531.
    View in: PubMed
    Score: 0.036
  65. Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond. Prev Med. 2021 10; 151:106595.
    View in: PubMed
    Score: 0.034
  66. Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-Based Cohort of Patients With Cirrhosis of Multiple Etiologies. Clin Gastroenterol Hepatol. 2021 07; 19(7):1443-1450.e6.
    View in: PubMed
    Score: 0.032
  67. Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps. Gastroenterology. 2020 08; 159(2):502-511.e2.
    View in: PubMed
    Score: 0.031
  68. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015 Jul 01; 121(13):2281-5.
    View in: PubMed
    Score: 0.022

© 2024 Kaiser Permanente